Association between DHEAS and Bone Loss in Postmenopausal Women: A 15-Year Longitudinal Population-Based Study

[1]  Eve Donnelly,et al.  The assessment of fracture risk. , 2010, The Journal of bone and joint surgery. American volume.

[2]  G. Zhai,et al.  Natural history and risk factors for bone loss in postmenopausal Caucasian women: a 15-year follow-up population-based study , 2008, Osteoporosis International.

[3]  Matthew T. Haren,et al.  Lower serum DHEAS levels are associated with a higher degree of physical disability and depressive symptoms in middle-aged to older African American women. , 2007, Maturitas.

[4]  P. Lakatos,et al.  CYP3A7*1C Polymorphism, Serum Dehydroepiandrosterone Sulfate Level, and Bone Mineral Density in Postmenopausal Women , 2007, Calcified Tissue International.

[5]  P. Nasca,et al.  The association between body mass index and osteoporosis in patients referred for a bone mineral density examination. , 2006, Journal of women's health.

[6]  I. Lambrinoudaki,et al.  Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women , 2005, Journal of Bone and Mineral Metabolism.

[7]  H. Bozkaya,et al.  The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women. , 2004, Journal of women's health.

[8]  E. Tok,et al.  The effect of circulating androgens on bone mineral density in postmenopausal women. , 2004, Maturitas.

[9]  H. Burger,et al.  The relative effect of endogenous estradiol and androgens on menopausal bone loss: a longitudinal study , 2004, Osteoporosis International.

[10]  S. Heymsfield,et al.  Relationship of leptin and sex hormones to bone mineral density in men , 2003, Acta Diabetologica.

[11]  W. Leowattana.  DHEA(S): the fountain of youth. , 2001, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[12]  M. Hill,et al.  The pathophysiological implications of circulating androgens on bone mineral density in a normal female population , 2000, Steroids.

[13]  W. Kohrt,et al.  Effects of DHEA replacement on bone mineral density and body composition in elderly women and men , 2000, Clinical endocrinology.

[14]  P. Delmas,et al.  Biochemical Markers of Bone Turnover, Endogenous Hormones and the Risk of Fractures in Postmenopausal Women: The OFELY Study , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  B. Allolio,et al.  Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens. , 1999, The Journal of clinical endocrinology and metabolism.

[16]  G G Klee,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Relationship of Serum Sex Steroid Levels and Bone Turnover Markers with Bone Mineral Density in Men and Women: A Key Role for Bioavailable Estroge , 2022 .

[17]  C. Labrie,et al.  Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat. , 1998, The Journal of endocrinology.

[18]  J. Simard,et al.  DHEA and the Intracrine Formation of Androgens and Estrogens in Peripheral Target Tissues: Its Role during Aging , 1998, Steroids.

[19]  L. Melton,et al.  Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis Foundation , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  A. Iranmanesh,et al.  Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study. , 1996, The Journal of clinical endocrinology and metabolism.

[21]  M. Szathmári,et al.  Dehydroepiandrosterone sulphate and bone mineral density , 1994, Osteoporosis International.

[22]  Harry K. Genant,et al.  Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. , 1993, The American journal of medicine.

[23]  T. Spector,et al.  The relationship of obesity, fat distribution and osteoarthritis in women in the general population: the Chingford Study. , 1993, The Journal of rheumatology.

[24]  E. Barrett-Connor,et al.  A prospective study of dehydroepiandrosterone sulfate (DHEAS) and bone mineral density in older men and women. , 1993, American journal of epidemiology.

[25]  S. Cummings,et al.  Bone density at various sites for prediction of hip fractures , 1993, The Lancet.

[26]  K. Khaw,et al.  Endogenous sex hormones and bone mineral density among community-based postmenopausal women. , 1992, Postgraduate medical journal.

[27]  L. Perry,et al.  The relationship between sex steroids and bone mineral content in women soon after the menopause , 1991, Clinical endocrinology.

[28]  T. Chard,et al.  A relationship between sex hormone binding globulin and dehydroepiandrosterone sulfate in normally menstruating females. , 1987, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[29]  G. Hodgen,et al.  Adrenarche: a survey of rodents, domestic animals, and primates. , 1978, Endocrinology.

[30]  J A Kanis,et al.  Treatment of established osteoporosis: a systematic review and cost-utility analysis. , 2002, Health technology assessment.

[31]  J. Hopper,et al.  A Prospective Study of Bone Loss in Menopausal Australian-Born Women , 1998, Osteoporosis International.